Vega Therapeutics, Inc
2 clinical trials · Sponsor
◉ Watch Vega Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD) (NCT07115004) | Vega Therapeutics, Inc | 2025-10-15 |
| Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) (NCT05776069) | Vega Therapeutics, Inc | 2023-03-16 |
Track Vega Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.